Mundipharma: all 120 studies
Page 2 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain PatientsTerminatedNCT01014559Phase 3
- Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate AsthmaCompletedNCT00995800Phase 2
- Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of PainCompletedNCT00992576Phase 2/3
- A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth PainTerminatedNCT00947466Phase 1/2
- OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA SubjectsCompletedNCT00902837Phase 3
- Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.CompletedNCT00854867Phase 1
- Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell MalignanciesCompletedNCT00823355Phase 1
- Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.TerminatedNCT00742495Phase 1/2
- Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe AsthmaCompletedNCT00734318Phase 3
- Trial of Forodesine in Patients With Relapsed B-cell Chronic Lymphocytic LeukemiaTerminatedNCT00646165Phase 1
- A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an InfusionTerminatedNCT00626600Phase 3
- An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible AsthmaCompletedNCT00563056Phase 3
- A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainCompletedNCT00513656Phase 2
- Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible AsthmaCompletedNCT00476073Phase 3
- Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With AsthmaCompletedNCT00475813Phase 3
- Oxycodone-naloxone in Relieving Opioid-related ConstipationCompletedNCT00412152Phase 3
- Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related ConstipationCompletedNCT00412100Phase 3
- A Randomised Open Controlled Parallel Group Study Comparing Norspan and TramadolCompletedNCT00399178Phase 4
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back PainCompletedNCT00346047Phase 3
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic PainCompletedNCT00345787Phase 3